E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer

Autor: Razvi Khalil, Keow Peh B, Huak Chan Y, Brendan Pang NK, Bajic Vladimir B, Kothandaraman Narasimhan, Salto-Tellez Manuel, Choolani Mahesh

Publikováno v: BMC Cancer, Vol 10, Iss 1, p 64 (2010)

Abstract Background Ovarian epithelial cancer (OEC) usually presents in the later stages of the disease. Factors, especially those associated with cell-cycle genes, affecting the genesis and tumour progression for ovarian cancer are largely unknown.

Externí odkaz: https://doaj.org/article/880bb2abed9e4d9b8c663d4f4861c61d

E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer.

Autor: Kothandaraman N; Diagnostic Biomarker Discovery Laboratory, Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University Health System, 5 Lower Kent Ridge Road, 119074, Singapore., Bajic VB, Brendan PN, Huak CY, Keow PB, Razvi K, Salto-Tellez M, Choolani M

Publikováno v: BMC cancer [BMC Cancer] 2010 Feb 24; Vol. 10, pp. 64. Date of Electronic Publication: 2010 Feb 24.